CXCR3 and neoplasm: Upon transfer of IL-15 activated Cxcr3−/− NK cells, 5T33-bearing mice showed more than 50% reduction of tumor cell frequency in BM compared with mice treated with Cxcr3+/+ IL-15 activated cells or vehicle.